Thursday, March 16, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIAID Immunology Quality Assessment Program

by Global Biodefense Staff
June 14, 2013

HIVThe National Institute of Allergy and Infectious Diseases (NIAID) has issued a request for proposals in support of the Immunology Quality Assessment Program (IQA), whose purpose is to assess the ability of laboratories to accurately and reliably determine data important for the meaningful interpretation of therapeutic and prevention clinical trials and studies. 

The IQA provides assistance and training when laboratories have difficulties and facilitates the adaptation, standardization and quality assessment of new immunological assay methodologies for use in NIAID supported investigations with particular focus on novel, point-of-care for diagnosis and disease monitoring.

With the increased research emphasis on T cell activation and inflammation in HIV disease, as well as the study of vaccines in pediatric populations, the IQA shall also be required to provide assistance to laboratories to standardize research-use-only tests and design measures to ensure quality and reliability. 

IQA will continue to support laboratories that are part of current and future NIAID-sponsored clinical trial networks. During the course of the contract it may be necessary to incorporate additional laboratories to support new NIAID-supported clinical trials.

The contract history of this IQA program includes:

  • 1988 – 1993 Initial award to FAST Systems Inc., Gaithersburg, MD
  • 1993 – 1998 Award to FAST Systems Inc., Gaithersburg, MD
  • 1998 – 2007 Award to the University of Medicine and Dentistry New Jersey
  • 2007 – 2014 Award to Duke University, Durham, NC

Full requirements of the program are available under Solicitation Number: RFP-NIAID-DAIDS-NIHAI2012150. The response deadline is September 12, 2013.

Tags: Request for Proposals

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC